Logo
Thursday, 18 April 2024
Thursday, 04 May 2023 12:00 am

US Dental Membrane and Bone Graft Substitute Market is expected to reach US$ 12,769.00 million by 2028

US Dental Membrane and Bone Graft Substitute Market is growing at a CAGR of 11.4% to reach US$ 12,769.00 million by 2028 from US$ 6,824.56 million in 2023 by Type, Procedure, and End User.

By The Insight Partners

Grafting Procedures Segment to Lead US Dental Membrane and Bone Graft Substitute Market during 2023–2028

According to our latest study on “US Dental Membrane and Bone Graft Substitute Market Forecast to 2028 – COVID-19 Impact and Country Analysis – by Type, Procedure, and End User,” the market is projected to reach US$ 12,769.00 million by 2028 from US$ 6,824.56 million in 2022; it is estimated to grow at a CAGR of 11.4% from 2023 to 2028.

The report highlights the key factors governing the market growth and prominent players with their developments in the market. The growth of the US dental membrane and bone graft substitute market is primarily attributed to the increasing burden of periodontal diseases and oral cancer and increase in demand for dental cosmetic procedures across the US. However, limitations and misconceptions associated with of reimbursement policies is restraining the market growth.

Based on type, the US dental membrane and bone graft substitute market is further segmented into dental bone graft substitutes, dental barrier membrane, grafting procedures, and dental soft tissue regeneration. The grafting procedures segment would hold the largest market share in 2022. The growth of the market for this segment is attributed to an increase in periodontal diseases and grafting procedures. However, the dental soft tissue regeneration segment is expected to register the highest CAGR in the forecasted period. Soft tissue regeneration includes augmentation around dental implants, root coverage, gingival augmentation, and soft tissue ridge augmentation. It is highly important in periodontology and oral and maxillofacial surgery. Complications such as bleeding, pain, swelling, and, in rare cases, numbness or infection can occur. In addition to aesthetics, the volume and quality of the soft tissue are important for oral health in many ways.

Increasing Burden of Periodontal Diseases and Oral Cancer is Expected to Bolster the US Dental Membrane and Bone Graft Substitute Market Growth

Periodontal diseases range from simple gingivitis to serious conditions that cause significant damage to the soft tissues and bones that support teeth; in the worst case, teeth are lost. Periodontal disease is a major public health problem in the US, and many adults in the country currently have some form of this disease. A study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR), showed that periodontal disease is associated with an increased risk of multiple cancers in postmenopausal women. According to an article “The Link between Periodontal Disease and Oral Cancer—A Certainty or a Never-Ending Dilemma” published in the Multidisciplinary Digital Publishing Institute (MDPI), more than 50% 18-year-old population in the US has periodontitis, and 75% of the population over 35 has some form of periodontitis. The severity of periodontitis is also variable. According to different studies, 30–50% of these diseases are mild, and 5–15% are severe and generalized.

In the US, a national health interview survey has reported a high prevalence of periodontitis based on oral health assessments; the prevalence of periodontitis among adults older than 30 is estimated at ~47%, rising to 70% in those aged 65 and above. The prevalence of moderate and severe periodontitis, which is more closely associated with systemic inflammation and the immune response, is very high in adults over 65.

Cancer is one of the major public health concerns and the second leading cause of death in the US. According to the US Department of Health and Human Services, oral cancer accounts for ~3% of cancer cases diagnosed annually in the US. Yearly, ~48,000 people are diagnosed with oral cancer, and ~9,600 die of the condition. According to the CDC, mouth and throat cancer cases account for 3% of cancer cases diagnosed annually in the US in 2020. Risk factors for oral cancer include tobacco use, excessive alcohol consumption, and HPV infection. Periodontal disease can lead to resorption and failure of the alveolar bone, loss of periodontal attachment, and loosening & falling of the teeth. Therefore, treatment of periodontal disease focuses on eliminating the source of infection, stimulating factors, and pays attention to repairing periodontal tissue defects and restoring normal morphology & function. Bone grafting is done for repairing periodontal defects by grafting materials (bone or bone substitutes) to restore the anatomical morphology of the alveolar bone and the function of the periodontal tissue. Therefore, the growing cases of periodontal diseases and oral cancer contribute to the US dental membrane and bone graft market growth.

Dentsply Sirona Inc, Dentium Co Ltd, Geistlich Pharma AG, ZimVie Inc, Keystone Dental Inc, Straumann Holding AG, Medtronic Plc, BioHorizons Inc, MEDOSIS, and LifeNet Health Inc. are a few of the leading companies operating in the US dental membrane and bone graft substitute market.

The Report Segments US Dental Membrane and Bone Graft Substitute Market as Follows:

The US dental membrane and bone graft substitute market is segmented on the basis of type, procedure, and end-user. Based on type, the market is further segmented into dental bone graft substitutes, dental barrier membrane, grafting procedures, and dental soft tissue regeneration. The grafting procedures segment is likely to hold the largest share of the market in 2022. However, dental soft tissue regeneration segment is anticipated to register the highest CAGR in the market during the forecasted period. Based on procedure, the US dental membrane and bone graft substitute market is further bifurcated into dental barrier membrane and grafting procedures. The grafting procedures segment held the largest market share in 2022 and the same is anticipated to register the highest CAGR during the forecast period. Based on end-user, the US dental membrane and bone graft substitute market is sub-segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com


The Insight Partners :    https://www.theinsightpartners.com

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.


Smarter Decisions with Smart News

Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.

Subscribe to our newsletter
Get the latest in your inbox weekly Sign up for the fully charged newsletter
© The News and Media Division of The Insight Partners 2024 | All Rights Reserved | Privacy Policy